Moazzam Shahzad1,2
Sibgha Gull Chaudhary1Iqra Anwar1Muhammad Arslan1Zehra Naseem1Naira T. Fatima1
Sakina Abbas1Tayyaba Ali1Raheel S. Siddiqui1
Peiman Hematti3Sunil H. Abhyankar1Joseph P. McGuirk1
Muhammad Umair Mushtaq1*- 1Division of Hematologic Malignancies & Cellular Therapeutics, University of Kansas Medical Center, Kansas City, MO, United States
- 2Department of Medicine, St Mary's Medical Center, Huntington, WV, United States
- 3Division of Hematology/Oncology, University of Wisconsin School of Medicine & Public Health, Madison, WI, United States
We conducted a bibliometric analysis to identify scholarly impact and factors associated with the top 100 cited articles on clinical hematopoietic stem cell transplantation (HSCT). In January 2021, a title-specific search was conducted. Non-HSCT and pre-clinical (in-vitro and animal) studies were excluded. A total of 39,406 records were identified and a list of the top 100 articles was made. Articles included in our study were characterized by the citations received, publication year, topic, study design, authors, h-index, and institutions. Linear regression analyses were performed. The 100 most cited articles were published over 52 years from 1968 to 2020, with a maximum number of articles (n = 40) published in the 1990s decade. Top-100 articles were cited 62,002 times with a median citation count of 465 (range 336–2240). The top-cited articles originated from 12 countries. United States contributed 69 articles. The University of Washington Fred Hutchinson Cancer Center (n = 15) was the leading institution. Blood (n = 32) and New England Journal of Medicine (n = 31) made the greatest contribution, and 52 manuscripts were clinical trials. The first author's H-index significantly correlated with citation count while journal impact factor, years since publication, first author's gender, and the number of authors did not have a significant association with the number of citations. In a multivariate regression model, the first author's h-index (regression coefficient 5.46, 95% confidence interval 2.99 to 7.93, p < 0.001) independently correlated with the citation count. Our study highlights the most influential articles on clinical HSCT and provides valuable insight for future research needs of the specialty.
Background
Hematopoietic stem-cell transplantation (HSCT), the most widely used cellular immunotherapy, was first performed by E. Donnell Thomas in 1957 as a new form of treatment for hematologic malignancies and has evolved into an adoptive immune therapy for malignant and non-malignant hematologic and immune disorders with a potential for cure (1). As a potentially lifesaving treatment, HSCT not only requires careful selection of stem-cell donors, recipients, and conditioning regimens but also close monitoring and aggressive management of clinical complications (2).
Bibliometric analysis constitutes the determination and evaluation of impact of research and scholarly publications with the help of techniques like the analysis of citations to assess the effect of a particular manuscript over a specified period of time (3). This serves as a mode to evaluate educational achievement for authors, as the number of citations a paper receives is usually proportional to the influence of that paper in a particular discipline (3). Large data sets can be examined by bibliometric methods and can help decision making regarding individuals, institutions, and organization. Citations are less susceptible to manipulation and are a reliable indicator (4). Since 1987, bibliometric analyses have been published on various fields of medicine (5); however, a bibliometric analysis of top-cited articles on HSCT is yet to be done. In this study, we conducted a bibliometric analysis to evaluate, identify, and characterize the 100 top-cited articles on HSCT to highlight the current state-of-the-art of the specialty and identify directions for future clinical research.
Methods
Data Sources and Search Strategy
The Clarivate Analytics Web of Science core collection (WoS) was accessed in January 2021 and a title-specific search was conducted using the MeSh terms and keywords “hematopoietic stem-cell transplantation,” “transplantation, hematopoietic stem cell,” “stem cell transplantation, hematopoietic,” “bone-marrow transplantation,” “transplantation, bone marrow,” “grafting, bone marrow,” “bone marrow grafting,” “transplantation bone marrow cell,” “bone marrow cell transplantation,” “stem cell transplant,” “allogeneic hematopoietic stem cell transplant,” “autologous hematopoietic stem cell transplant.” A total of 39,406 records were identified (6).
Data Extraction
A list of the top 100 cited articles was compiled and arranged in descending order according to the WoS number of citations. Data were collected for study title, study design, study population, study topic, number of citations, journal name, journal impact factor (IF), and number of authors. The study design was classified as review, meta-analysis, retrospective, prospective, randomized/non-randomized clinical trials, and guidelines/consensus. Clinical studies in HSCT were included in the analysis. Non-HSCT and pre-clinical (in-vitro and animal) studies were excluded. The primary and corresponding author's information included: author name, gender, affiliations, and h-indices. If the corresponding author was the last author, then primary author's information was used. Data were extracted by four authors (MA, ZN, NF, and SA) independently to ensure accuracy. The extracted data were double-checked by MS. and MM.
Data Analysis
Data were analyzed using SPSS version 21. Descriptive statistics were used to describe characteristics of 100 top-cited articles. Top 100-cited articles were categorized by year. Factors associated with five or more manuscripts among top-100 cited articles were explored including the journals, first authors' characteristics (institution, country, H-index), and study details (type and topic). Linear regression analysis was performed and regression coefficients (R) with 95% confidence intervals (CI) were obtained. In univariate and multivariate linear regression analyses, number of citations received by an article were compared with gender, years since publication, journal IF, and the number of authors. Statistical significance was considered at p < 0.05.
Results
The 100 most cited articles in the field of HSCT were included (Supplementary Table 1). Top-100 articles were cited 62,002 times with a median citation count of 465 (range 334–2240). Among the top 100, only nine articles were cited more than 1000 times, while three articles were cited more than 2000 times. The 100 most cited articles in the field were published over 52 years from 1968 to 2020. The 10-year interval from 1991–2000 had the highest number of publications (n = 40) (Figure 1). The years 1988 and 1999 had the greatest number of publications accounting for seven manuscripts each.
Figure 1. The 100 top-cited articles on hematopoietic stem cell transplantation by 10-year intervals.
Blood (n = 32) and New England Journal of Medicine (n = 31) had the highest number of publications. The top-cited articles originated from 12 countries and the United States (US) contributed 69 articles. Bone marrow transplantation was the most discussed topic (n = 21), and a clinical trial was the most common manuscript type (n = 52). The University of Washington Fred Hutchinson Cancer Center (n = 15) was the leading institution. Thirteen authors had five or more manuscripts in the top-100 articles, and Rainer Strob, MD had the highest number of publications (n = 12) (Table 1).
Table 1. Factors associated with five or more articles in the 100 top-cited articles on hematopoietic stem cell transplantation.
In univariate linear regression analyses, the first author's h-index (R 5.42, 95% CI 3.11 to 7.73, p < 0.001) correlated with the citation count while, years since publication (R −4.62, 95% CI −13.78 to 4.54, p = 0.319), journal impact factor (R 2.48, 95% CI −0.57 to 5.53, p = 0.109), first author's gender (R 83.72, 95% CI −148.76 to 316.21, p = 0.477) and the number of authors (R 1.33, 95% CI −13.18 to 15.85, p = 0.856) did not have a significant association with the number of citations. In multi-variate linear regression analysis adjusted for years since publication, journal impact factor, first author's gender and the number of authors, the first author's h-index (R 5.46, 95% CI 2.99 to 7.93, p < 0.001) remained an independent predictor of the citation count.
Discussion
Our study highlights the 100 most cited articles on hematopoietic stem cell transplantation. Clinical trials were the main study type with a peak increase in publications between 1991 to 2000. The scarcity of studies before the 1990s demonstrates recent advancements in HSCT. Previous bibliometric analysis has demonstrated the highest contributions to stem cell research were made in the past two decades (7). Although the first human bone marrow transfusion was given to a patient suffering from aplastic anemia in 1939 (8), our findings revealed that the majority of the highly cited papers were not cited until 1968, in contrast to previous bibliometric analysis in neurosurgery (9).
Blood, the official journal of the American Society of Hematology, and the New England Journal of Medicine were the top-cited journals. Although authors centralize their publications in journals with wider readership and higher impact factors, we did not find a significant correlation between the impact factor of a journal and the number of citations it received. The US contributed a major number of publications similar to a previous study in stem cell laboratory research but in contrast, our study has a minimal contribution from Asia (7).
There are several limitations of our analysis. While categorizing articles in descending order according to the number of citations, older manuscripts were higher in the top 100 as compared to recent publications. The reason could be that the latest publications are cited fewer times during the years preceding their publication. We only used WoS for our literature search and took the top 100 WoS cited articles that can be different from other citation databases; however, WoS is considered a standard citation database for medical research as well as more accurate in document type labelling (10).
Conclusion
To our knowledge, this is the first study to identify the 100 most cited papers on clinical HSCT. Our study highlights themost influential articles on HSCT, centralization of research to North American and European institutions, and provides valuable insight for future research needs of the specialty.
Data Availability Statement
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author/s.
Author Contributions
All authors contributed to the manuscript and fulfilled criteria per the uniform requirements set forth by the International Committee of Medical Journal Editors (ICJME) guidelines. All authors contributed to the article and approved the submitted version.
Conflict of Interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher's Note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Acknowledgments
The content of this manuscript has been presented at the American Society of Hematology Annual Meeting 2021, Top 100 Cited Articles on Hematopoietic Stem Cell Transplantation: A Bibliometric Analysis. Blood. 2021; 138: 4790.
Supplementary Material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fmed.2022.872692/full#supplementary-material
References
1. Bazinet A, Popradi G. A general practitioner's guide to hematopoietic stem-cell transplantation. Curr Oncol. (2019) 26:187. doi: 10.3747/co.26.5033
2. Copelan EA. Hematopoietic stem-cell transplantation. N Engl J Med. (2006) 354:1813–26. doi: 10.1056/NEJMra052638
3. Cooper ID. Bibliometrics basics. J Med Libr Assoc. (2015) 103:217–8. doi: 10.3163/1536-5050.103.4.013
4. Holden G, Rosenberg G, Barker K. Tracing thought through time and space: a selective review of bibliometrics in social work. Soc Work Health Care. (2005) 41:1–34. doi: 10.1300/J010v41n03_01
5. Garfield E. 100 citation classics from the Journal of the American Medical Association. JAMA. (1987) 257:52–9. doi: 10.1001/jama.1987.03390010056028
6. Web of Science Core Collection. Web of Science. Available online at: s/ Last (Accessed May 1, 2021).
7. Lin CL, Ho Y-S. A bibliometric analysis of publications on pluripotent stem cell research. Cell J. (2015) 17:59.
8. Osgood EE, Riddle MC, Mathews TJ. Aplastic anemia treated with daily transfusions and intravenous marrow; case report. Ann Intern Med. (1939) 13:357–67. doi: 10.7326/0003-4819-13-2-357
9. Ponce FA, Lozano AM. Highly cited works in neurosurgery. Part I: the 100 top-cited papers in neurosurgical journals: A review. J Neurosurg. (2010) 112:223–32. doi: 10.3171/2009.12.JNS091599
Keywords: hematopoietic stem cell transplant, bibliometric analysis, citation classics, Hematology, Oncology
Citation: Shahzad M, Chaudhary SG, Anwar I, Arslan M, Naseem Z, Fatima NT, Abbas S, Ali T, Siddiqui RS, Hematti P, Abhyankar SH, McGuirk JP and Mushtaq MU (2022) Top 100 Cited Articles on Clinical Hematopoietic Stem Cell Transplantation: A Bibliometric Analysis. Front. Med. 9:872692. doi: 10.3389/fmed.2022.872692
Received: 09 February 2022; Accepted: 04 May 2022;
Published: 06 June 2022.
Edited by:
Pentti Nieminen, University of Oulu, FinlandReviewed by:
Eberval Figueiredo, University of São Paulo, BrazilAndy Wai Kan Yeung, University of Hong Kong, China
Copyright © 2022 Shahzad, Chaudhary, Anwar, Arslan, Naseem, Fatima, Abbas, Ali, Siddiqui, Hematti, Abhyankar, McGuirk and Mushtaq. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Muhammad Umair Mushtaq, bW11c2h0YXEmI3gwMDA0MDtrdW1jLmVkdQ==